PERSONAL DETAILS


Prof. Dr. Anita Zarina Binti Bustam @ Mainudin

Professor
Faculty of Medicine Dean\'s Office
Faculty of Medicine
 
  +603-79492185
  +603-79563072
  anitabustam@um.edu.my
  Faculty of Medicine Dean\'s Office, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, MALAYSIA
 
ResearcherID Link
  http://www.researcherid.com/rid/B-8233-2010


BIBLIOMETRIC DATA


 Total Articles in Publication List  23
 Articles With Citation Data  20
 Sum of the Times Cited   172
 Average Citations per Article   8.60
 h-index   7
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • FARO, Elected Council Member, 2014, (International)
  • SEAROG, Exco Member, 2014, (International)
  • NPC Society of Malaysia, Exco Member, 2011-2013, (National)
  • NPC society of Malaysia, Life Membership, 2011, (National)
  • SEAROG, Committee Member, 2011-2013, (International)
  • Academy of Medicine Malaysia, Member, 2009, (National)
  • Asia Pacific Hospice Network, Member, 2003-2007, (International)
  • Malaysian Oncological Society, Committee, 2001, (National)
  • Malaysian Oncological Society, Life Member, 2000, (National)
  • Royal College of Radiologists, London, Member, 1995, (International)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Ahli Jawatankuasa PPGP, Department Of Oncology, Faculty Of Medicine, 01-Oct-13
  • Postgraduate Curriculum Working Group, Department Of Oncology, Faculty Of Medicine, 23-Sep-14
  • Programme Coordinator, Department Of Oncology, Faculty Of Medicine, 01-Sep-14 - 01-Sep-16
  • Quality Manager, Department Of Oncology, Faculty Of Medicine, 01-Jul-14 - 01-Jul-16
  • Head of Department, Department Of Oncology, Faculty Of Medicine, 01-Aug-00 - 31-Aug-13
  • Head Coordinator, Department Of Oncology, Faculty Of Medicine, 01-Oct-02 - 31-Aug-13
  • Head, Unit Onkologi Klinikal, Faculty Of Medicine Dean's Office, Faculty Of Medicine, 01-Sep-12 - 31-Aug-13
  • National Project Coordinator for IAEA project RAS6040, National, 01-Jan-05 - 31-Dec-09

AREAS OF EXPERTISE
(Area).


  • Clinical Oncology Which Covers All Aspects Of Non-Surgical Treatment Modalities For Cancer Patients In Particular With Radiotherapy, Cytotoxics, Hormones And Biologics. Tumour Site Specialization Includes Breast,lung, Brain, Lymphoproliferative Tissue, Paediatrics And Skin.


RECENT SELECTED PUBLICATIONS
(Publication).



Article In Academic Journals
2015
  • Vincent Chee Ee Phua, Wei Quan Wong, Pei Lin Tan, Anita Zarina Bustam, Marniza Saad, Adlinda Alip, Wan Zamaniah Wan Ishak. Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice (ISI-Cited Publication)
  • Yahaya NA1, Subramanian P, Bustam AZ, Taib NA.2015.Symptom Experiences and Coping Strategies among Multi- ethnic Solid Tumor Patients Undergoing Chemotherapy in Malaysia.Asian Pac J Cancer Prev 16(2):723-30. (ISI-Cited Publication)
  • Chandramathi S, Suresh K, Anita ZB, Rokiah P, Kuppusamy UR. Urinary Advanced Oxidation Protein Product (AOPP): A Potential Oxidation Damage Marker for Cancer . West Indian Medical Journal, In press. (ISI-Cited Publication)

2013
  • Zain RB, Athirajan V, Ghani WM, Razak IA, Raja Latifah RJ, Ismail SM, Sallam AA, Bustam AZ, Rahman ZA, Hussien A, Talib N, Cheong SC, Jallaludin A.2013 An oral cancer biobank initiative: a platform for multidisciplinary research in a developing country. Cell Tissue Bank. 14(1):45-52 (ISI-Cited Publication)
  • Nor Zuraida Zainal, Norley Shuib, Anita Zarina Bustam, Zuraida Ahmad Sabki, Ng Chong Guan. 2013. Reliability and Validity of the Malay Version of the Breast-Impact of Treatment Scale (MVBITS) in Breast Cancer Women undergoing Chemotherapy. Asian Pacific J Cancer Prev, 14 (1), 463-468 (ISI-Cited Publication)

2012
  • Chee Ee Phua, Anita Zarina Bustam, Mastura Md Yusof, Marniza Saad, Cheng-Har Yip, Nor Aishah Taib and Char Hong Ng. 2012 Risk of treatment related death (TRD) with adjuvant chemotherapy for breast cancer: A study in University Malaya Medical Centre (UMMC). Journal of Cancer Therepeutics & Research 1: 13 (SCOPUS-Cited Publication)
  • Phua Chee Ee, Anita Zarina Bustam,Mastura Md Yusof, Marniza Saad,Yip Cheng-Har, Nor Aishah Taib, Ng Char Hong, Teh Yew Ching 2012. Risk of Treatment Related Death and Febrile Neutropaenia with Taxane-Based Adjuvant Chemotherapy for Breast Cancer in a Middle Income Country Outside a Clinical Trial Setting. Asia Pacific Journal of Cancer Prevention; 13(9), 4623-4626. (ISI-Cited Publication)

2011
  • Chandramathi S,Suresh K,Anita ZB,Kuppusamy UR (2011). Infection of Blastocystis hominis and microsporidia: are they opportunistic? Trans. R. Soc. Trop. Med. Hyg. (ISI-Cited Publication)

2010
  • Shingo Kato, Tatsuya Ohno, Kullathorn Thephamongkol, Yaowalak Chansilpa, Yang Yuxing, C.R.Beena Devi, Anita Z. Bustam, Miriam J.C. Calaguas, Rey H. De Los Reyes, Chul-Koo Cho, To Anh Dung, Nana Supriana, Hideyuki Mizuno, Takashi Nakano, Hirohiko Tsujii. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia. Int J Radiation Oncology Biol Phys Vol 77 No 3 pg 751-757, 2010 (ISI-Cited Publication)
  • Seriramalu R, Pang W, Jayapalan JJ, Mohamed E, Abdul- Rahman PS, Bustam AZ, Khoo ASB, Hashim OH;Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasked reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 31:14, 2388-2395 Jul 2010 (ISI-Cited Publication)
  • Lau Peng Choong, Nur Aishah Mohd Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Yip Cheng Har; High Tumour Stage and Margin Clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia; Asian Pacific Journal for Cancer Prevention,11,1409-1416 Dec 2010 (ISI-Cited Publication)
  • Hoong-Yin Chong, Nur Aishah Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Cheng-Har Yip. Treatment options for locally advanced breast cancer - experience in an Asian tertiary hospital. APJCP, 11:2010;1-5. (ISI-Cited Publication)
  • Prognostic Factors for Elderly Breast Cancer Patients in University Malaya Medical Centre, Malaysia CE Phua1*, AZ Bustam2, Cheng-Har Yip3, Nor Aishah Taib3 2010 Asian Pacific J Cancer Prev, 11, 1205-1211 (ISI-Cited Publication)

2009
  • S.Chandramathi,K.Suresh,Z.B.Anita,U.R.Kuppusamy. Elevated levels of urinary hydrogen peroxide, advanced oxidative protein product (AOPP) and malonaldehyde in humans infected with intestinal parasites.Cambridge University Press. Parasitology (2009) 136, 359-363 (ISI-Cited Publication)
  • S. Chandramathi, K. Suresh, Z. B. Anita, U. R. Kuppusamy. Attenuation of serum H2O2 and FRAP levels in colorectal cancer patients with intestinal parasitic infection. Mal J Med Sci (2009) 16(2), 15-20 (SCOPUS-Cited Publication)

2008
  • S.Chandramathi,K.Suresh,Z.B. Anita,U.R.Kuppusamy. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J cancer Res Clin Oncol (2009) 135:319-325 Published online 29 Aug 2008 (ISI-Cited Publication)
  • Emida Mohamed1 ,Puteri Shafinaz Abdul-Rahman1, Saeid Reza Doustjalali1,Yeng Chen1, Boon-Kiong Lim2, Siti Zawiah Omar2, Anita Zarina Bustam3, Vivek Ajit Singh4, Nur Aishah Mohd-Taib5, Cheng-Har Yip5, Onn Haji Hashim1.1Dept of Molecular Medicine, 2Dept. Of Obstetrics and Gynaecology, 3Clinical Oncology Unit, 4Dept. Of Orthopaedic Surgery, 5Dept. Of Surgery, Faculty of Medicine, University of Malaya. Lectin- based electrophoretic analysis of the expression of the 35 kDa inter- - trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. 2008, 29, 2645-2650 (ISI-Cited Publication)

2007
  • Nor ZAINAL, Koh HUI, Ting HANG and Anita BUSTAM. Department of Psychological Medicine and Clinical oncology Unit, Faculty of Medicine, Universiti Malaya. Prevalence of distress in cancer patients undergoing chemotherapy. Asia Pacific Journal of Clinical Oncology 2007; 3: 219-223 (Full paper) (ISI-Cited Publication)

2006
  • Saeid R. Doustjali, Rohana Yusof, Gopala K. Govindasamy, Anita Z. Bustam, Bhanumathy Pillay, and Onn H. Hashim. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. The Journal of Medical Investigation Vol. 53 No. 1,2, February, 2006 (Full paper) (SCOPUS-Cited Publication)
  • Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H Reece, Manfred Lehnert.Gemcitabine and split dose paclitaxel or docetaxel in metastatic breast cancer: a randomized phase II study. European Journal of Cancer 42 (2006) 1797-1806 (Full paper) (ISI-Cited Publication)

2005
  • Si Lay Khaing, V Sivaratnam, Siti Zawiah Omar, Anita Zarina Bustam, Mun Kein Seong. Case Report: Small cell carcinoma of uterine cervix in a teen-aged girl a rare occurrence. Malaysian Journal of Obstetrics & Gynaecology 2005: Vol. 8 No. 9: 62-67 (Full paper) (Non-ISI/Non-SCOPUS Cited Publication)
  • R.B. Zain, Raja Latifah RJ, Razak IA, Ismail SM, Atiya SA, Hashim BY, Jallaludin A, Bustam AZ, Rahman ZAA, Krishnan G, Kipli NP, Samsudin AR, Nasir WM, Mahadzir WMW, Abraham MT, Norma J, Tay KK, Yuen KM, Cheong SC and Other MOCRI team members. Oral cancer and Precancer in Malaysia The Database and Tissue Resource Bank. Oral Oncology, MacMillan India; 2005. Vol 10: 3-12 (Full paper) (Non-ISI/Non-SCOPUS Cited Publication)

Proceeding
2006
  • Pawanchek M, Ung N-M*, Bustam A* and Ng K-H. Department of Biomedical Imaging, University of Malaya, *Clinical Oncology Unit, University of Malaya. In-vivo skin dose assessment for breast cancer during radiotherapy treatment using gafchromic film (EBT) detector. Proceedings 29th Annual General Meeting & Scientific Meeting of the College of Radiology Malaysia 3-4 June 2006. (Abstract) 

2005
  • 5.R.B. Zain, R.J. Raja Latifah, I.A. Razak, S.M. Ismail, A.R. Samsuddin, S.A. Atiya, B.Y. Hashim, A. Jallaludin, W.M. Nasir, S.C. Cheong, A.Z.Bustam, W.M.W. Mahadzir, M.T.Abraham, Z.A.A. Rahman, G. Krishnan, N.P. Kipli, J. Norma, K.K. Tay, K.M. Yuen and other MOCRI Team Members. University of Malaya, Universiti Sains Malaysia, Ministry of Health Malaysia, Cancer Research Initiatives Foundation, Malaysia. Oral cancer and precancer research in Malaysia-the database and tissue resource bank. Proceedings of the 10th International Congress on Oral cancer, 19-24th April 2005, Island of Crete, Greece. Oral Oncology Supplement; April 2005; Vol 1 No 1; pp 123 (Abstract) 

2004
  • K.-S. Khoo, M. Zaidi, V. Srimuninnimit, Z. F. Jiang, P. Prem Kumar, A. Bustam, A. H. Villalon, M. Lehnert; National Cancer Centre, Singapore;Baquai Institute of Oncology, Karachi, Pakistan; Siriraj Hospital, Mahidol University, Bangkok, Thailand; 307 Hospital, Academy of Military Medical Sciences, Beijing, China; MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; University Malaya Medical Centre, Kuala Lumpur, Malaysia; Manila Doctors Hospital, Manila, Philippines; Eli Lilly Asian Operations Ltd, Hong Kong, China.Randomized phase II trial of three gemcitabine (GEM)-taxane combinations in metastatic breast cancer (MBC). Vol. 23, 2004 American Society of Clinical Oncology Meeting Proceedings- (Abstract) 

2001
  • Abdul Wahid, A Bustam, F Hayat P Rassiah and U Prasad.Re-treatment of 14 patients with recurrent nasopharyngeal carcinoma using CT simulation and conformal therapy. Radiotherapy and Oncology, Vol. 58 (Supplement1) pg.S97, 6th International Congress of Radiation Oncology Melbourne, Aus, Jan/Feb 2001- (Abstract) 

Others
2003
  • National Clinical Practice Guideline for Breast Cancer Published by MOH/Academy of Medicine Launched in September 2003 

2001
  • Radiation Therapy of Stage IIIB Cervical cancer for Asians Report and Guideline from the Cooperative Group Trial. Published by Asia Cooperation Center, Japan Atomic Industrial Forum, Inc. Launched in September 2001 

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Source), (Level).


  • A randomised open label phase 3 study of single agent pembrolizumab vs single agent chemo per physician's choice for metastatic triple negative breast cancer-[KEYNOTE-119 study], Principal Investigator(PI), 2015-2018, MSD, International
  • A Phase III Randomised, Double-Blind,Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting, Co-Investigator, 2014-2016, Samsung Bioepis, International
  • A Prospective Cohort Study of Patients with Malignant Cord Compression, Co-Investigator, 2014-2015, NUS, International
  • Phase II randomized study of docetaxel with or without low-dose, short course sunitinib in the treatment of advanced solid tumors., Co-Investigator, 2013-2015, NONE
  • JACOB study:A Double-Blind, Placebo-Controlled, Randomized, Multicenter Phase III Study Evaluating The Efficacy and Safety of Pertuzumab in Combination with Trastuzumab and Chemotherapy in Patient with HER-2 Positive Metastatic Gastroesophageal Junction and Cancer, Principal Investigator(PI), 2013-2015, Roche, National
  • Oral Cancer Research: Diagnostic And Biobanking Services, Co-Researcher, 24/06/2013, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), 24/12/2015
  • Prospective study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics and pharmacodynamics in Asian women with hormone receptor-positive advanced breast cancer, Co-Investigator, 2013-2015, NONE
  • ABI-PRO- 3002 A phase 3, randamized, double-blind, placebo-controlled study of abiraterone acetate )JNJ-212082) plus prednisone in asymtomic or mildly symptomatic patients with metastatic castration-resistant prostate cancer, Co-Investigator, 2012-2015, Quintiles Janseen Cilaq, National
  • Biobanking of Oral Cancers: An Assessment of Survival, Clinicopathological Parameters, Management Strategies Nutrition and Genetic Susceptibility of Patients, Co-Investigator, 2011-2015, High Impact Research (HIR)
  • Lapatinib study Phase II open-labelstudy of preoperativeweeklypac55 litaxel and carboplatinwithlapatinib (Tykerb ) in patientswith ErB2-positive stage I-III Breastc ncer, Co-Investigator, 2011-2013, High Impact Research (HIR)
  • HKI 3004 Adjuvant breast cancer study in HER2 positive patients using neratinib., Principal Investigator(PI), 2010-2014, Pfizer, International
  • ASPECCT Panitumumab vs cetuximab for the third line treatment of advanced colorectal cancer., Co-Investigator, 2010-2012, Amgen, International
  • AGILE Axitinib in metastatic renal cell carcinoma patients., Co-Investigator, 2010, Pfizer, International
  • The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique, Principal Investigator(PI), 2010-2011, Postgraduate Research Grant(PPP), National
  • ASCOLT Aspirin in treating patients with Dukes stage C colon or rectal cancer, or high risk Dukes stage B colon cancer that has been completely removed by surgery., Co-Investigator, 2010-2015, NCC Singapore, International
  • Phase 3 open label first line treatment for HER2 positive breast cancer comparing Paclitaxel plus herceptin vs Paclitaxel plus Neratinib., Co-Investigator, 2010-2012, Pfizer, International
  • D- CARE A Randomised Double- Blind, Placebo- Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence, Co-Investigator, 2010-2015, Amgen, International
  • 2009AG-013736 (Axitinib) as Second Line Therapy for Asian Patients with Metastatic Renal Cell Cancer, Co-Investigator, 2009-2011, Pfizer, International
  • LUME-Lung 2 An international, multi-centre phase III randomised controlled trial for second line treatment of recurrent, advanced non-small cell lung cancer, comparing pemetrexed + placebo versus pemetrexed + BIBF1120 (a multi-targeted tyrosine kinase inhibitor)., Principal Investigator(PI), 2009-2012, Boehringer-Ingelheim, International
  • Phase 3b, randomised, open-label study of Bevacizumab + Temsirolimus vs Bevacizumab + Interferon-alfa as first-line treatment in subjects with advanced renal cell carcinoma., Co-Investigator, 2008-2012, Wyeth, International
  • A Phase 2 Biomarker identification Trial for Erlotinib in patients with Advanced Pancreatic carcinoma (MARK study), Principal Investigator(PI), 2008-2011, Roche, International
  • Clinical trials any solid tumour in particular breast cancer., Principal Investigator(PI), 2008, 
  • Induction and concurrent chemoradiation with cetuximab for treatment of locally advanced Nasopharyngeal Carcinoma, Co-Investigator, 2008-2012, Geran Penyelidikan Universiti Malaya (UMRG), National
  • A prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy. (SHARE Study), Co-Investigator, 2008-2010, Short Term Research Fund (Vote F)(PJP), National
  • A multinational, randomised, open-label, phase 3 study of sunitinib malate vs sorafenib in patients with advanced hepatocellular carcinoma., Co-Investigator, 2008-2011, Pfizer, International
  • An international multi-centre phase III randomised controlled trial of first line treatment of advanced renal cell carcinoma, comparing bevacizumab + interferon-alpha versus bevacizumab + torisel., Co-Investigator, 2008-2012, Wyeth
  • A Prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy (SHARE Study), Co-Investigator, 2008-2010, Geran Penyelidikan Universiti Malaya (UMRG), National
  • BEATRICE, Principal Investigator(PI), 2008-2014, Genentech, International
  • Development of Risk Models and Management Strategies for Oral Cancer, Co-Investigator, 2007, ScienceFund, National
  • A multi-institutional study on the clinical outcome of patients with nasopharyngeal carcinoma (NPC) and the establishment of a Malaysian NPC tissue bank., Co-Investigator, 2007-2008, MOH, National
  • A phase 3 multicentre, randomised, placebo- controlled trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy regimens in subjects with previously treated metastatic breast cancer., Co-Investigator, 2007-2010, Genentech
  • A Phase II, Open-label, Randomised, Multicenter Trial of GW786034 (Pazopanib) in combination with Lapatinib (GW 572016) compared to Lapatinib alone as first line therapy in subjects with advanced or metastatic breast cancer with erb-B2 FISH positive tumours., Co-Investigator, 2007-2008, GSK, International
  • SATURN/TITAN- A Multicentre, double blind randomized phase 3 study to evaluate the efficacy of Tarceva or placebo following 4 cycles of platinum-based chemotherapy in patients with histologically documented or advanced or recurrent or metastatic NSCLC who have not experienced disease progression or unacceptable toxicity during chemotherapy, Principal Investigator(PI), 2006-2011, Roche, International
  • A Phase III trial of novel Epothilone BMS-247550 plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant., Principal Investigator(PI), 2005-2008, BMS, International
  • Phase II, open label study of SB-715992 in subjects with advanced or metastatic breast cancer., Co-Investigator, 2004-2008, GSK, International
  • Oral cancer and precancer in Malaysia-risk factors, prognostic markers, genetic expression and impact on quality of life., Co-Investigator, 2004, IRPA, National
  • Concurrent weekly Cisplatin and radiotherapy for advanced cervical cancer., Co-Investigator, 2003-2008, FNCA, Japan, International
  • Randomised Phase 2 trial of Gemcitabine combined with a Taxane for metastatic breast cancer., Principal Investigator(PI), 2001-2003, Eli Lilly, International

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • MEASUREMENT OF BLADDER VOLUME VARIATIONS USING PORTABLE ULTRASOUND EQUIPMENT: INTRODUCTION OF DRINKING PROTOCOL, Reviewer, 2013-2013, BIIJ
  • The treatment outcome of radical radiotherapy in laryngeal cancer, Article reviewer, 2013-2013, BIIJ
  • Eribulin in breast cancer treatment, Consultant, 2013-2013, Eisai Malaysia Sdn Bhd
  • Penilaian ubat-ubatan kemoterapi, AJK teknikal, 2012-2012, UMMC
  • Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC), Article reviewer, 2012-2012, MJM
  • Radiation Oncology training in Malaysia, Consultant, 2012-2012, IAEA
  • Head of panel of judges for oral presentations at ASCOMOS 2012, 2012-2012, Malaysian Oncological Society
  • Erlotinib in first line EGFR mutation positive NSCLC, Consultant, 2012-2012, Roche
  • Radioimmunotherapy-Based Treatment of Cancer, Article reviewer, 2011-2011, BIIJ
  • Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer, Article reviewer, 2009-2009, BIIJ
  • Medulloblastoma: Cranial spinal junctional techniques., Article reviewer, 2008-2008, BIIJ
  • Asia Pacific Cancer Conference 2011, Organising Committee, 2008-2011, Malaysian Oncological Society
  • Poster presentations MOS 2008, Poster judge, 2008-2008, Malaysian Oncological Society
  • International Atomic Energy Agency (IAEA) Project RCA RAS 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in the Region ., Project Coordinator, 2005-2009, International Atomic Energy Agency (IAEA)
  • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM), Committee Member, 2003-2003, UKM
  • 37th Malaysia-Singapore Congress of Medicine, Scientific Committee, 2003-2003, Academy of Medicine
  • National cancer registry, Advisory Committee, 2003-2007, Ministry of Health
  • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM), Committee Member, 2003-2003, UKM
  • Annual Scientific meetings, Committee member, 2001-2003, Malaysian Oncological Society
  • MOS Annual Scientific Meeting, Chairman of Scientific Committee, 2001-2001, Malaysian Oncological Society

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2012, (UNIVERSITY)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2009, (UNIVERSITY)
  • Eskpo Penyelidikan, Rekacipta dan Inovasi UM 2009, Universiti Malaya, 2009, (UNIVERSITY)
  • Sijil Khidmat Cemerlang, Universiti Malaya, 2007, (UNIVERSITY)
  • Bronze medal for the category of Fundamental Research: Oxidative stress biomarkers in breast cancer. Eskpo Penyelidikan, Rekacipta dan Inovasi 2006, 18-20 Julai , Universiti Malaya, 2006, (UNIVERSITY)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2006, (UNIVERSITY)
  • Gold medal for the category of Invention & Innovation sempena Eskpo Penyelidikan, Rekacipta dan Inovasi 2005, 14-17 Jun. Oral Cancer Database Software- Real and Virtual Tumor Bank System (OCDS/RVTBS)- An Aid for Multicenter Studies. , Universiti Malaya, 2005, (UNIVERSITY)
  • Sijil Khidmat Cemerlang, Universiti Malaya, 2005, (UNIVERSITY)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2003, (UNIVERSITY)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2002, (UNIVERSITY)
  • Anugerah Khidmat Cemerlang, Universiti Malaya, 2001, (UNIVERSITY)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


Invited Speaker
  • Development of oncology training in middle income countries: the Malaysian model, AROICON 2015, 29 Nov 2015 to 29 Nov 2015, AROI, (International)
  • An overview of cancer services in Malaysia; a virtual tour of Clin Onco Dept UMMC ; Oncology training in Malaysia, Department of Radiation Oncology, Technical University Munich Seminar, 04 Apr 2014 to 04 Apr 2014, Department of Radiation Oncology, Technical University Munich, (International)
  • Hormonal therapy in breast cancer, 1st UMMC breast cancer public forum, 18 Oct 2014 to 18 Oct 2014, Breast cancer resource centre,UMMC, (Others)
  • Recurrent and metastatic NPC: issues and challenges, NPC research day, 04 Mar 2013 to 04 Mar 2013, NPC Society Malaysia/Universiti Malaya, (National)
  • Radiotherapy planning for breast cancer, Moving from 2D to 3D conformal radiotherapy workshop IAEA MAL 6020, 20 Jun 2012 to 22 Jun 2012, MOH, (National)
  • clinical research forum, 5th national conference on clinical research, 24 Jun 2011 to 24 Jun 2011, ministry of health malaysia, (National)
  • Radiation Therapy for cancer, Seminar perawatan Onkologi, 28 Sep 2010 to 28 Sep 2010, PTj Pembangunan Insan, (University)
  • Pengenalan Kanser Wanita dan Rawatan, Seminar kanser wanita dari perspektif biopsikososial, 11 Nov 2008, PTj Kebajikan Perubatan, PPUM, (National)
  • Oncology Endpoints: Their relevance in advanced cancer., Palliative Care Symposium: Clinical Decision making and Ethics in Advanced Cancer, 18 Apr 2007, Faculty of Medicine, UM, (National)
  • An overview of radiation therapy in cancer treatment., A Continuous Professional Development Course in Radiotherapy, 20 Dec 2005 to 22 Dec 2005, Radiology Dept., FOM, UM, (National)
  • Radiotherapy of BAVM, Basic Neuro-interventional Course, 11 Mar 2004 to 12 Mar 2004, Radiology Dept, FOM, UM, (University)
  • Follow-up of treated breast cancer patients, MOS Annual Scientific Meeting, 20 Sep 2002 to 22 Sep 2002, MOS, (National)
  • Hormone therapy, Oncology in Palliative Care Seminar, 29 Jul 2001, Hospis Malaysia, (National)
Event Organiser
  • Not applicable, APCC 2011, 10 Nov 2011 to 11 Nov 2011, MOS, (International)
  • None, MOS Annual Scientific Meeting, 28 Sep 2002 to 30 Sep 2001, MOS, (National)
Poster
  • Prospective controlled study on the role of scalp hypothermia to prevent chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy., APCC 2011, 10 Nov 2011 to 11 Nov 2011, MOS, (International)
  • Psycho-Oncology Referrals- A Single-Centre Review from Malaysia, IPOS 12th World Congress of Psycho-Oncology, 25 May 2010 to 29 May 2010, (International)
  • DEVELOPMENT OF SPECIALIST TRAINING PROGRAMME IN CLINICAL ONCOLOGY: THE MALAYSIA EXPERIENCE, ICARO 2009, 27 Apr 2009 to 29 Apr 2009, IAEA, (International)
Presenter
  • Clinical Oncology training in Malaysia, 1st FARO Council Member meeting, 30 May 2015 to 30 May 2015, Japan as host country, (International)
  • Key Performance Indices, Ministry of Health Workshop on Quality Assurance in Radiotherapy, 01 Aug 2006, MOH, (National)
  • Concurrent chemoradiotherapy for cervical cancer (CERVIX-III), FNCA workshop on Radiation Oncology, 13 Dec 2004 to 17 Dec 2004, FNCA, (International)
Others
  • not applicable, ESMO Penang, 22 Jan 2015 to 25 Jan 2015, MOS and ESMO, (International)
  • Not applicable, JACOB study Investigator Meeting, 06 Mar 2013 to 08 Mar 2013, Roche, (International)
  • Not applicable, World conference on lung cancer, 27 Oct 2013 to 30 Oct 2013, IASLC, (International)
  • Not applicable, Asia Pacific Breast Cancer Summit, 12 Apr 2013 to 13 Apr 2013, (International)
  • not applicable, ASCOMOS 2012, 08 Sep 2012 to 08 Sep 2012, MOS, (National)
  • Report on Lung cancer statistics, NCR Report Writing Workshop for year 2003-2005, 02 Mar 2007 to 04 Mar 2007, MOH, (National)
  • None, 37th Malaysia-Singapore Congress of Medicine, 05 Sep 2003 to 07 Sep 2003, Academy of Medicine, (National)

SUPERVISION


Post Graduate Level
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)
Completed
  • Masters Degree, Mahzom Pawanchek, In vivo skin dose assessment for breast cancer dring radiotherapy treatment using gafchromic film (EBT) detector, 2005/2006
  • Masters Degree, Sin Sze Yarn, The evolution of 2-D to 3-D radiation therapy practice in the treatment of nasopharyngeal carcinoma., 2004/2005
  • Masters Degree, Nik Muhd Aslan Abdullah, Concurrent chemoradiation for patients with nasopharyngeal carcinoma treated in UMMC between 2001 and 2003., 2006/2007
  • Masters Degree, Vincent Phua Chee Ee, Analysis of breast cancer in elderly women:cohort of 1994-2004 treated in UMMC, 2007/2008
  • Masters Degree, Ramarao A/L Seriramalu, Proteomic studies in patients with NPC: lectin-based approach, 2007/2008
  • Masters Degree, Mastura Md Yusuf, Concurrent chemoradiotherapy in H&N cancer, 2008/2009
  • Masters Degree, Nor Aziyan Yahya, Symptoms prevalence, characteristics and coping strategies among adult oncology patients., 2009/2010
  • Masters Degree, Mohd Azhar Musa, Dosimetric comparison of the Enhanced Dynamic Wedge and the Physical Wedge and its clinical implications
  • Masters Degree, Si Lay Khaing, Assessment of patients with carcinoma of the cervix treated with definitive radiotherapy at UMMC., 2003/2004
  • Masters Degree, Lim Chun Sen, Radiation-induced hypothyroidism following radical radiotherapy for head and neck cancer, 2010/2011
  • Masters Degree, Halim Abdul Rahman, The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique, 2010/2011
  • Masters Degree, Azura Deniel, Clinical supervision, 2002/2003
  • Masters Degree, Wan Zamaniah Wan Ishak, Clinical supervision, 2004/2005
  • Masters Degree, Rozita Abdul Malik, Clinical supervision, 2004/2005
  • Masters Degree, Fabian Lee Wei Yuen, Clinical supervision, 2004/2005
  • Masters Degree, Kua Voon Fong, Cinical supervision, 2005/2006
  • Masters Degree, Chan Wee Han, Clinical supervision, 2005/2006
  • Masters Degree, Lau Kah Liew, Clinical supervision, 2006/2007
  • Masters Degree, Hayani Abdul Wahid, Clinical supervision, 2006/2007
  • Masters Degree, Ros Suzanna Ahmad Bustamam, Clinical supervision, 2006/2007
  • Masters Degree, Yu Kong Leong, Clinical supervision, 2006/2007
  • Masters Degree, Flora Chong Li Tze, Clinical supervision, 2007/2008
  • Masters Degree, Lee Wei Ching, Clinical supervision, 2007/2008
  • Masters Degree, Hafizah Zaharah Ahmad, Clinical supervision, 2007/2008
  • Masters Degree, Ibtisam Muhammad Nur, Clinical supervision, 2007/2008
  • Masters Degree, Suhana Yusak, Clinical supervision, 2008/2009
  • Masters Degree, Natasha Mohd Hashim, Clinical supervision, 2008/2009
  • Masters Degree, Fong Chin Heng, Clinical supervision, 2008/2009
  • Masters Degree, Cheah Soon Keat, Clinical supervision, 2008/2009
  • Masters Degree, Vaishnavi Jeyasingam, Clinical supervision, 2009/2010
  • Masters Degree, Wong Yoke Fui, Clinical supervision, 2010/2011
  • Masters Degree, Nahjatul Kursyiah Abd Ghafar, Clinical supervision, 2011/2012
  • Masters Degree, Tang Weng Heng, Clinical supervision, 2011/2012
  • Masters Degree, Harissa Husainy Hasbullah, adjuvant trastuzumab in early breast cancer: a`retrospective cohort study in two oncology centres in malaysia, 2012/2013
  • Masters Degree, Muthukumaran, Clinical supervision, 2009/2010

Terminated
  • Masters Degree, Siti Zaleha Md Sani, Clinical supervision, 2008/2009
  • Masters Degree, Atiliana Mohamed Adib, Clinical supervision, 2009/2010
  • Masters Degree, Noor Syuhadah A. Karim, Clinical supervision, 2009/2010
  • Masters Degree, Farah Zaffar Hayat, Clinical supervision, 2002/2003
  • Masters Degree, Tan Boon Seang, Clinical supervision, 2003/2004
  • Masters Degree, Adlan Suhaimi Ahmad, Clinical supervision, 2003/2004
  • Masters Degree, Yang Rashidi Abdullah, Clinical supervision, 2004/2005
  • Masters Degree, Chandra Kumar A/L Krishnan, Clinical supervision, 2005/2006
  • Masters Degree, Ng Poh Huat, Clinical supevision, 2005/2006
  • Masters Degree, Sunitha Kumaran, Clinical supervision, 2010/2011
  • Masters Degree, Han Albert Dicken, Clinical supervision, 2011/2012

Ongoing
  • Masters Degree, Harissa Husainy Hasbullah, Clinical supervision, 2009/2010
  • Masters Degree, Leong Siew Mooi, Clinical supervision, 2010/2011
  • Masters Degree, Tan Chih Kiang, Clinical supervision, 2010/2011
  • Masters Degree, Astrid Sinarti Hassan, Clinical supervision, 2010/2011
  • Masters Degree, Arnil George Sirimanne, Clinical supervision, 2010/2011
  • Masters Degree, Noorzulali Haron, Clinical supervision, 2008/2009
  • Masters Degree, Malwinder Singh Sandhu, Clinical supervision, 2010/2011
  • Masters Degree, Santhi Nadarajan, Clinical Supervision, 2011/2012
  • Masters Degree, Soma Bavani Sivaraj, Clinical supervision, 2011/2012
  • Masters Degree, Junie Khoo Yu Yen, Clinical supervision, 2011/2012
  • Masters Degree, Marfuah Nik Eezamuddeen, Clinical supervision, 2011/2012
  • Masters Degree, Winnie Ng Nyek Ping, Clinical supervision, 2011/2012
  • Masters Degree, Ina Shaliny Duraisamy, Clinical supervision, 2011/2012
  • Masters Degree, Ng Boon Huat, Clinical supervision, 2011/2012
  • Masters Degree, Prathepamalar Yehgambaram, Clinical supervision, 2012/2013
  • Masters Degree, Ang Tick Suan, Clinical supervision, 2012/2013
  • Masters Degree, Eznal Izwadi Mohd Mahidin, Clinical supervision, 2012/2013
  • Masters Degree, Sucharit Pongprakyun, Clinical supervision, 2012/2013
  • Masters Degree, Sow We Jen, Clinical supervision, 2013/2014
  • Masters Degree, Fiona Suling Lian, Clinical supervision, 2013/2014
  • Masters Degree, Teo Yin Keong, Clinical supervision, 2013/2014
  • Masters Degree, Khairiyah Sidek, Clinical supervision, 2013/2014
  • Masters Degree, Noor Zafifah Zakaria, Clinical supervision, 2013/2014
  • Masters Degree, Tan Li Mei, Clinical supervision, 2013/2014
  • Masters Degree, Choong Swee Hsia, Clinical supervision, 2013/2014
  • Masters Degree, Narendran, Timing and outcome of palliative chemotherapy, 2015/2016
  • Masters Degree, Shadwa, Clinical supervision, 2014/2015
  • Masters Degree, Lim Yaeh Ni, Clinical supervision, 2014/2015
  • Masters Degree, Narendran K, Clinical supervision, 2014/2015
  • Masters Degree, Lim Yi Way, Clinical supervision, 2014/2015
  • Masters Degree, Gan Ben Jin, Clinical supervision, 2014/2015
  • Masters Degree, Syadwa, Timing and outcome of palliative radiotherapy., 2015/2016
First Degree/Diploma/Pre-Degree
(Course Title), (Academic Session), (No. of Candidates)
Ongoing
  • Describing the clinical management and resource use of solid tumour patients with chemotherapy-related febrile neutropenia in UMMC, 2012/2013, 1

INTELLECTUAL PROPERTY RIGHTS
(Product Name), (Type), (Reference), (Year), (Level).


  • Master of Clinical Oncology Programme Syllabus, literary work, 2013, (University)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Medical Advisory Committee member. Advise on clinical issues at UMMC., UMMC, Committee Member, 2001-Present, (University)
  • Structuring, data collection, analysis and report writing, National Cancer Registry, Advisor, 2003-2007, (National)
  • International Atomic Energy Agency (IAEA) Project Coordinator for project RCA RAS 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in the Region., IAEA, Coordinator, 2005-2009, (International)
  • To give input with regards to the conduct and management of clinical trials and in particular industry sponsored trials managed by Clinical Investigation Centre, UM, Clinical Investigation Centre, Faculty of Medicine , UM, Committee Member, 2005-Present, (University)
  • Organising Committee for APCC 2011, Malaysian Oncological Society, Committee Member, 2008-present, (National)
  • Clinical Oncology Specialty Committee, Universiti Malaya, Chairman, 2009-present, (National)
  • Radiation oncology curriculum in developing countries, IAEA, Consultant , 2012-2012, (International)
  • Penilaian ubat-ubatan kimoterapi, Pusat perubatab Universiti Malaya, Committee Member, 2012-2012, (University)
  • Root cause analysis, UMMC, Committee Member, 2013-2013, (Hospital level)
  • Evaluate suitability of nindetanib esilate in advanced NSCLC for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia, Expert Advisor, 2015-2015, (National)
  • Evaluate suitability of vismodegib in advanced basal cell carcinoma for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia, Expert Advisor, 2015-2015, (National)

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).


Post Graduate
  • Master of Clinical Oncology, 2015/2016, 7, 6
  • Master of Clinical Oncology, 2015/2016, 11, 300
  • Master of Clinical Oncology, 2014/2015, 11, 304
  • Master of Clinical Oncology, 2013/2014, 16, 110
  • Master of Clinical Oncology, 2012/2013, 12, 304
  • Master of Medical Physics, 2012/2013, 7, 2
  • Master of Clinical Oncology, 2011/2012, 10, 312
  • Master of Medical Physics, 2011/2012, 5, 2
  • Master of Clinical Oncology, 2010/2011, 8, 312
  • Master of Clinical Oncology, 2009/2010, 10, 312
  • Master of Clinical Oncology, 2008/2009, 7, 309
  • Master of Clinical Oncology, 2007/2008, 7, 309
  • Master of Clinical Oncology, 2006/2007, 8, 315
  • Master of Medical Physics, 2006/2007, 6, 2
  • Master of Otorhinolaryngology, 2005/2006, 10, 3
  • Master of Clinical Oncology, 2005/2006, 7, 244
  • Master of Medical Physics, 2005/2006, 2, 2
  • Master of Clinical Oncology, 2004/2005, 5, 369
  • Master of Clinical Oncology, 2004/2005, 5, 366
  • Master of Clinical Oncology, 2004/2005, 5, 370
  • Master of Internal Medicine, 2004/2005, 8, 1
  • Master of Obstetrics & Gynaecology, 2004/2005, 2, 48
  • Master of Medical Physics, 2004/2005, 5, 2
  • Master o0f Medical Physics, 2003/2004, 5, 5
  • Master of Clinical Oncology, 2003/2004, 3, 364
  • Master of Clinical Oncology, 2002/2003, 3, 368
  • Master of Medical Physics, 2002/2003, 4, 4
  • Master of Medical Physics, 2001/2002, 4, 3
  • Master of Medical Physics, 2000/2001, 3, 3
First Degree
  • UMMP, 2015/2016, 8, 6
  • UMMP, 2015/2016, 160, 2
  • UMMP, 2015/2016, 24, 30
  • UMMP, 2014/2015, 8, 8
  • MBBS, 2007/2008, 150, 2
  • Basic degree in Nursing Sciences, 2007/2008, 30, 1
  • Basic degree in Nursing Sciences, 2006/2007, 39, 2
  • MBBS, 2006/2007, 150, 2
  • MBBS, 2005/2006, 150, 2
  • Basic degree in Nursing Sciences, 2004/2005, 40, 2
  • MBBS, 2004/2005, 160, 2
  • basic degree in nursing sciences, 2003/2004, 40, 3
  • MBBS, 2003/2004, 231, 2
  • Basec degree in nursing sciences, 2002/2003, 40, 2
  • MBBS, 2002/2003, 215, 2
  • basic degree in nursing sciences, 2001/2002, 40, 3
  • MBBS, 2001/2002, 163, 2
  • MBBS, 2000/2001, 153, 2
  • Basic degree in nursing sciences, 2000/2001, 40, 2
Diploma (If Applicable)
  • Diploma in Radiography, 2004/2005, 27, 1
  • Diploma in Radiography, 2004/2005, 27, 1
  • Diploma in Radiography, 2003/2004, 27, 3
  • Diploma in Radiography, 2002/2003, 23, 3
  • Diploma in Radiography, 2001/2002, 24, 3
  • Diploma in Radiography, 2000/2001, 21, 3
Others
  • Advanced Diploma in Nursing (Oncology), 2008/2009, 8, 3
  • Advanced Diploma in Nursing (Oncology), 2006/2007, 9, 3
  • Advanced Diploma in Nursing (Oncology), 2004/2005, 15, 2
  • Advanced Diploma in Nursing (Oncology), 2003/2004, 18, 2

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).


  • Advanced Diploma in Nursing Oncology (UM), Programme evaluator , 
  • Medulloblastoma: Cranial spinal junctional techniques., Article reviewer , 
  • Poster presentations, Judge for poster presentations , 
  • Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM), Academic Programme Evaluator , 
  • Symptoms burden and QoL. Comparison between CAM and non-CAM users during breast cancer chemotherapy in 2 public hospitals in Malaysia., Thesis ,  (2015-2015)
  • marking exam scripts and viva voce, master of clinical oncology ,  (2015)
  • Palliative to curative treatment: A case of stage 4 mucinous adenocarcinoma successfully treated with metronomic capecitabine in combination with bevacizumab and surgery., Article In Journal ,  (2015-2015)
  • Editorial board member for International Journal of Recent Research in Life Sciences (IJRRLS), Article In Journal ,  (2014)
  • Appointed as external assessor from UCSI University to assess suitability of an academic staff from UCSI for promotion from assoc. prof. to full prof., To assess suitability of candidate for promotion ,  (2013-2013)
  • The treatment outcome of radical radiotherapy in laryngeal cancer., Article reviewer ,  (2013-2013)
  • Master of Clinical Oncology Part 1,2 and Final Exam, Mark exam scripts and conduct clinical exam ,  (2013)
  • MJM Chemotherapy extravasation at Hospital Pulau Pinang Malaysia, Article reviewer ,  (2013-2013)
  • Survival of primary lung cancer patients treated in Brunei darussalam, External Examiner ,  (2013-2013)
  • JUMMEC Case study: Squinting eyes: A presenting complaint in a young adult with glioblastome multiforme., Article reviewer ,  (2013-2013)
  • Metastatic melanoma to the stomach; a case report, Article reviewer ,  (2013-2013)
  • MEASUREMENT OF BLADDER VOLUME VARIATIONS USING PORTABLE ULTRASOUND EQUIPMENT: INTRODUCTION OF DRINKING PROTOCOL, Article In Journal ,  (2013-2013)
  • Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC), Article In Journal ,  (2012-2012)
  • Induction chemotherapy with paclitaxel, ifosfamide and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer., Article In Journal ,  (2009-2009)
  • Master of Clinical Oncology Part 1 Exam, Internal Examiner ,  (2006)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Women's Integration Society, (Local), 01-Jan-02
  • Breast cancer public forum, (Community), 18-Oct-14 until 18-Oct-14
  • SMK Seksyen 9 Shah Alam Niners A+ committee member, (Community), 01-Jul-13 until 12-Oct-13